SCHEMBL20109496

SCHEMBL20109496

OC1(Cc2ccccc2)CCCNC1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 5/20 0.46
CYP3A4 P08684 2/20 0.46
TSHR P16473 1/20 0.46
SLC6A4 P31645 8/20 0.43
SLC6A2 P23975 7/20 0.43
SLC6A3 Q01959 7/20 0.43
OPRL1 P41146 2/20 0.43
OPRM1 P35372 1/20 0.43
OPRD1 P41143 1/20 0.43
OPRK1 P41145 1/20 0.43
MAOA P21397 1/20 0.40
MAOB P27338 1/20 0.40
HTR2A P28223 2/20 0.39
USP2 O75604 1/20 0.39
ALDH1A1 P00352 1/20 0.39
CYP1A2 P05177 1/20 0.39
KCNH2 Q12809 2/20 0.38
TACR1 P25103 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5509592 0.89 SLC6A2 (0.47) CYP2D6TSHRSLC6A4SLC6A2SLC6A3
Hydrochloric Acid SCHEMBL18038811 0.88 OPRL1 (0.47) CYP2D6TSHRSLC6A4SLC6A2SLC6A3
SCHEMBL29057868 0.83 SLC6A2 (0.40) CYP2D6SLC6A4SLC6A2SLC6A3ALDH1A1
SCHEMBL27948436 0.83 CYP3A4 (0.32) CYP2D6CYP3A4TSHRSLC6A4SLC6A2
SCHEMBL1740342 0.81 OPRL1 (0.46) CYP2D6TSHRSLC6A4SLC6A2SLC6A3
Hydrochloric Acid SCHEMBL9938014 0.80 OPRL1 (0.49) SLC6A4SLC6A2SLC6A3OPRL1OPRM1
SCHEMBL4206116 0.79 OPRL1 (0.56) SLC6A4SLC6A2SLC6A3OPRL1OPRM1
SCHEMBL735823 0.79 OPRL1 (0.56) TSHRSLC6A4SLC6A2SLC6A3OPRL1
Trifluoroacetic Acid SCHEMBL21199460 0.78 SLC6A2 (0.40) CYP2D6SLC6A4SLC6A2SLC6A3KCNH2
SCHEMBL613290 0.78 OPRL1 (0.51) CYP2D6TSHRSLC6A4SLC6A2SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180118721-A1 PYRIMIDINE DERIVATIVES MERCK PATENT GMBH (DE) 2018-05-03 US disclosed
US-20180118721-A1 PYRIMIDINE DERIVATIVES MERCK PATENT GMBH (DE) 2018-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180118721-A1 PYRIMIDINE DERIVATIVES MTHFD1, TYMS, DPYD CYP2D6 631/4885CYP3A4 1630/4885TSHR 2945/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.